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ABSTRACT                                                                                                     
 
B-mode ultrasound measurement of the carotid intima-media 
thickness (CIMT) has been convincingly shown to be a 
predictor of coronary artery disease (CAD) in several studies. 
To my knowledge such assessments have not been carried 
out in the Black South African population, which hitherto had 
a low prevalence of CAD. However, with the increases in 
prevalence of a cluster of risk factors categorised as the 
Metabolic Syndrome (MS), CAD is inevitably on the increase. 
The purpose of this study was to evaluate the role of CIMT in 
predicting CAD in Black South Africans, and to correlate CIMT 
with the known risk factors for CAD, including those of the 
MS. 
My study has shown that CIMT predicts the extent of CAD as 
found at coronary angiography. Multiple regression analysis 
identified hypertension and fasting glucose as the most 
important determinants of CIMT. Age, obesity, smoking and 
LDL-Cholesterol also correlated positively with CIMT. The 
results suggest that in this population, hypertension and 
diabetes are crucial in the pathogenesis of thickening of the 
intima-media of carotid arteries, a surrogate marker of 
coronary artery disease. 
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1  INTRODUCTION 
Historically, coronary artery disease (CAD) is uncommon in Black South 
Africans. However, increasing urbanisation and a change to a sedentary 
lifestyle amongst Black people in South Africa has led to a changing pattern of 
heart disease1. Isaacson investigated the autopsy results from cardiac deaths 
at the Baragwanath Hospital (the largest hospital where Black patients are 
being treated) during the period 1959 -1960 and compared this to those of 
1976, noting that autopsy results are an approximation and may not be a true 
reflection of the incidence of cardiac deaths. Of the total number of autopsies 
performed, deaths from hypertension in 1959 were at 5.7%. The figure in 
1976 had risen to 7.5%. Similarly, the incidence of myocardial infarction in 
1959 was 0.9% and this increased to 11.7% in 1976. The increased incidence 
in cardiac deaths was largely due to an increase in myocardial infarction and 
hypertension.   
Urbanisation appears to be the major factor contributing to the increased 
incidence of myocardial infarction in South African Blacks. With urbanisation 
comes a lifestyle that is conducive to developing atherosclerosis: smoking, a 
Westernised diet that has high fat content and is low in fibre and reduced 
exercise. All these are contributing factors to the increasing incidence of 
CAD2.   
Angiography and Doppler ultrasound were techniques used earlier as 
surrogate markers to assess atherosclerosis3. Although these techniques 
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have great clinical value, they are not adequate for detection of early 
atherosclerotic changes.  Several papers attest to the fact that the 
measurement of the thickness of the intima and media layers of the carotid 
arteries by ultrasound is currently a widely accepted method to obtain reliable 
and reproducible evidence of early atherosclerosis3 4 5. 
There is insufficient research involving Black people in South Africa, where 
the incidence of CAD is increasing.   
Two important studies that were done involving Blacks in sub-Saharan Africa 
are, the ‘INTERHEART Africa’ study6, which looked at the association of risk 
factors in relation to acute MI and the other, ‘Hypertension in Sub-Saharan 
African Populations’, which looked at the prevalence and possible causes of 
hypertension in Blacks7. 
As far as I am aware of, no research has been done which included Black 
South Africans, in which B-mode ultrasound assessment of the carotid intima-
media thickness (CIMT) as a risk factor, is compared to the presence and 
extent of CAD, and to the presence of known risk factors for CAD, in order to 
determine the value of CIMT as a predictor for CAD. 
Hence research into whether carotid intima-media thickness could be a 
surrogate marker for coronary artery disease in the South African Black 
population is very relevant. 
 
                                                 
3
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4
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5
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2  LITERATURE REVIEW 
2.1  RISK FACTORS FOR CORONARY ARTERY DISEASE 
Risk Factors Associated with Myocardial Infarction in Africa. 
In more than 50% of all patients, myocardial infarction (MI) or other acute 
coronary syndromes are the first evidence of CAD. Therefore early detection 
of CAD allows for the introduction of effective treatment which may contribute 
to reducing mortality, through plaque stabilization and more aggressive 
control of atherosclerotic risk factors8. 
The increasing incidence of CAD in developing countries, and the fact that 
most of the published data around CAD comes from European countries, 
prompted the INTERHEART Africa Study (1999-2003)6, which looked at acute 
MI in sub-Saharan Africa. The INTERHEART study was designed to assess 
the association of CAD risk factors and acute MI at an international level.  
Nine countries participated in the INTERHEART Africa Study, with 80% of the 
participants coming from South Africa. Participants were divided into three 
groups in view of the diverse ethnic groups in South Africa, namely, Black 
Africans, Coloured Africans and European/other Africans.  
Results from the INTERHEART Africa Study were compared to results from 
the INTERHEART global study. The mean age at which the African cases 
presented with a MI for the first time was 54.3 (SD±11.3 years), which was 3.8 
years earlier than for the overall study cases. The degree of association for 
each of the major risk factors with acute MI in the African sample is consistent 
with that found in the global study. The risk factors with the strongest 
                                                 
8
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relationship to acute MI in the African sample were previous histories of 
diabetes and hypertension. The prevalence of hypertension was significantly 
higher in the total African population than in the global INTERHEART 
population. Obesity was also a significantly stronger risk factor for acute MI in 
the African group.  
The risk factors were generally consistent for all African groups, except for 
hypertension and smoking. In Black Africans hypertension was shown to have 
a stronger relationship to MI, whereas smoking showed a less striking 
relationship when compared to the other groups. Ironically, in Black Africans, 
rising affluence and higher education, important for transformation, was 
associated with an increase in the risk for MI, which is in contrast to other 
African groups. When compared to the overall INTERHEART group, a higher 
incidence of MI was found in the Black African group when there was a history 
of hypertension.  
 
2.1.1  Hypertension 
Hypertension in sub-Saharan Africa is a widespread problem and has a high 
prevalence in urban areas7. The exact data for South African Blacks is not 
known. A study was carried out in 1983, which included the adult population in 
Durban9. Results showed that hypertension was highest in urban Blacks 
(25%), intermediate in Whites (17%), lower in ethnic Indians (14%) and lowest 
in rural Blacks (9%). Another survey carried out in 1998, showed that of the 
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predominantly Black South African population over 60 years of age, 50-60% 
were hypertensive10. 
In Black patients, hypertension occurs at a very young age compared to 
Whites. No particular gender bias was found1.  Deaths frequently occur from 
cerebral haemorrhage, uraemia or congestive cardiac failure. It was predicted 
that the incidence of hypertension would increase with the stress induced by 
urbanisation.   
Opie and Seedat7 refer to a study carried out in the USA (the National Health 
and Nutritional Survey – NHANES), where a similar pattern for hypertension 
was found. Hypertension was more common in Blacks (32%) than in Whites 
(23%). The factors contributing to hypertension in Black Americans were no 
different to those in Africa. Obesity was found to be a major contributing factor 
in both South African and American Blacks. South African Black females were 
found to outweigh males in their prevalence of obesity. With a population 
estimated at 650 million, increasing longevity and a Westernised lifestyle, 
hypertension and the severity of its complications, will impact greatly on the 
economy of sub-Saharan Africa. As was found in the INTERHEART Africa 
study, the incidence of MI in sub-Saharan Africa is rising, with hypertension as 
the strongest risk factor. 
The effect of hypertension and smoking as single vascular risk factors on the 
CIMT was investigated by Csányi A, Egervári A and Nagy Z. (2001)11. They 
included participants that were hypertensive but with no other risk factors, and 
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participants who were smokers with no other risk factors. CIMT was 
measured at both sides of the distal common carotid artery. 
The largest increase in the CIMT was observed in the hypertensive group. 
Using multiple regression analysis they showed that only age, sex, smoking 
and hypertension correlated with CIMT significantly and independently 
(r=0.518, p=<0.0001). 
It has been suggested that hypertension is one of the factors that can cause 
endothelial damage. This theory is based on the “Response-to-Injury” model 
of atherosclerosis12.  According to this model, haemodynamic factors 
(particularly hypertension) and chemical factors in blood induce dysfunction of 
the endothelium. This injury may be followed by aggregation of blood 
platelets, oxidised lipids and smooth muscle cells in the intima, resulting in 
plaque formation. Thus hypertension and dyslipidaemias such as elevated low 
density lipoprotein serum cholesterol (LDL-C), established independent risk 
factors for increased CIMT13 may act inter-dependently to cause 
atherosclerosis, manifesting as increased CIMT. The effect on CIMT of 
hypertension and LDL-C was studied by Sun P, Dwyer KM, Merz CNB et 
al14. They used B-mode ultrasound to measure the intima-media thickness of 
the common carotid artery. Subjects for the study (n= 511) were drawn from 
those participating in the Los Angeles Atherosclerosis Study. To depict the 
relations between CIMT with serum LDL-C and systolic blood pressure (SBP), 
covariate-adjusted mean CIMT was estimated within subgroups of LDL-C and 
SBP. Subjects were categorised in terms of tertiles of SBP and then quintiles 
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of LDL-C within each blood pressure group. The results showed that CIMT is 
very strongly related to LDL-C under conditions of elevated SBP. CIMT was 
significantly related to LDL-C in the hypertensive (HYP) group. Results were 
similar for both sexes.  
The findings of their study support the Response-to-Injury model of 
atherogenesis. 
  
2.1.2  The Metabolic Syndrome (MS) 
The MS is a cluster of key risk factors having a significant impact on the 
prevalence of CAD. Significant risk factors for the MS appear to be obesity, 
insulin resistance, aging and hormonal imbalance. It appears that in the 
United States, the increasing obesity contributes significantly to the 
prevalence of the MS and findings indicate that measurements, particularly of 
abdominal fat, is of significant value in defining the syndrome15. 
Atherosclerosis and cardiovascular disease are directly related to factors that 
constitute the MS. Of these factors hypertension, fasting plasma glucose and 
dyslipidaemia appear as the most significant risk factors. A prothrombotic 
state and a pro-inflammatory state are frequent findings in subjects with the 
above factors. Atherogenic dyslipidaemia, including increased Low Density 
Lipoproteins (LDL-C), reduced High Density Lipoprotein Cholesterol (HDL-C) 
and elevated Triglycerides (TG), creates an aggregation of lipid disturbances 
which contributes to these states16. 
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Low HDL-C has been explored as an independent risk factor for CAD17.  The 
study group consisted of 18 patients who had family history of low HDL-C. 
The control group of n=18 were pair-matched for gender, age and body mass 
index (BMI), to maximise statistical power. All the subjects were free of CAD 
symptoms. 
The averages of the mean measurements of the CIMT were taken at the 
CCA, BULB and ICA, from three angles on either side. 
CIMT in the group with low HDL (<0.77mmol/L) was higher than the control 
group (r=0.70, p=0.0009). As with previous studies, age was found to be a 
significant contributor to the increased CIMT in both groups. The increment of 
CIMT across the years was significantly larger in the low HDL-C group, 
implying an increased risk of developing plaque.   
In this study, CIMT was found to be useful to detect early atherosclerotic 
changes in people with low HDL-C who are asymptomatic. 
 
Some researchers believe that the MS is not sufficient as predictor of the 10-
year risk for CAD. For those patients who are free of atherosclerotic 
cardiovascular disease or diabetes, the Framingham risk score (FRS) remains 
essential to estimate the10-year risk for CAD. In the FRS triglyceride levels, 
abdominal obesity and fasting glucose levels, important factors for the 
diagnosis of the MS, were not found to be significant in increasing the 
predictive value for CAD over and above the standard risk factors. These 
factors come into play in the longer term16. 
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2.1.2.1  Diagnosis of the Metabolic Syndrome 
There are differing criteria for this syndrome. The two most important 
classifications are the National Cholesterol Education Program (NCEP)18, 
which was proposed to provide criteria that are easily applicable in a clinical 
setting, and the recent International Diabetes Federation (IDF) classification19, 
which is similar to the NECP, but places a greater emphasis on obesity as 
measured by the waist circumference. For this dissertation the IDF 
classification is used, as listed below.  
NCEP  III Criteria 
Hypertension (>130/85 mmHg) 
Obesity as defined by abdominal circumference (>102 cm in men; 
>88cm in women) 
High TG level (>1.7 mmol/L) 
Low HDL-C level (<1.0 mmol/L for men; <1.3mmol/L for women) 
High fasting glucose level (>6.1 mmol/L) 
IDF  Criteria 
A. Central Obesity: waist circumference >94 cm for men and > 80 cm 
for women 
Plus any 2 of the 4 factors below 
B. Raised TG level > 1.7 mmol/L 
C. Reduced HDL-C <1.03 mmol/L in men, <1.29 mmol/L in women or 
specific treatment for these lipid abnormalities 
D. Raised BP: systolic BP >130, or diastolic BP >85 mmHg or 
treatment of previously diagnosed hypertension 
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E. Raised fasting plasma glucose: >5.6 mmol/L or previously 
diagnosed Type 2 diabetes. 
There is debate as to whether the NCEP or the IDF classifications provide the 
best possible estimate of the MS, in order to ascertain the best determinants 
for prevention and treatment. As indicated above, the increasing incidence of 
MS in the United States stems from the virtual epidemic of obesity and depicts 
a morbid scenario.  The prevalence is 24% for those older than 20 years and 
rises to >40% in those over 60 years15. 
The exact prevalence of MS in South African Blacks and its predictive value 
for CAD is unknown. 
 
2.1.3 Smoking 
There is no clear understanding of the pathophysiological mechanism which 
makes smoking a major risk factor for CAD for both sexes. Research has 
been constrained, because smoking interacts with other classical 
cardiovascular risk factors, which in combination, affects the progression of 
atherosclerosis20.   
It was found that particularly in men, cigarette smoking is recognised as a 
major risk factor for atherosclerosis and CAD21. The imaging protocol in that 
study, which was designed to evaluate the effect of cigarette smoking on 
intima-media thickness, included the distal segment of the CCA and the 
common femoral artery bilaterally, using only the far wall segments. The study 
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population consisted of 194 men and 330 women aged 17-65 years. The 
subjects were free from cardiovascular disease and had no other risk factors. 
Linear regressions were used to analyse the relationship between CIMT and 
age and CIMT and smoking. Multiple regression analysis was used for age 
and gender adjustment of the CIMT/smoking relationship. 
The findings showed an increased CIMT in men smokers (both CCA and 
femoral arteries) and also in former smokers, compared to never-smokers. 
However, this was not so in the case of women. 
 
Another study has also identified smoking as an independent risk factor11. 
Here the annual increase in CIMT was assessed in a healthy population 
without risk factors other than smoking and hypertension. 
The study population consisted of three groups, n = 258 (randomised): 
• a group of people who had hypertension (HYP) and no other risk 
factors (at least five years of treatment for hypertension);  
• a group of people who were smokers (SMO) without other risk factors 
(current smokers with a five pack-cigarette-year);  
• a group that was risk- and symptom free, healthy control subjects 
(HCS). 
The mean age was significantly higher in the HYP (p< 0.005) and SMO 
groups (p<0.001) groups than in the HCS group.  
Their results showed smoking as a single risk factor causing thickening of the 
intima-media layer of the CCA. The authors also indicate that their findings 
lend support to other studies where a similar trend was found and emphasise 
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smoking as positively, significantly and independently related to CIMT22. It 
was also the explanation why the CIMT was different in twins that were not 
matched for smoking23.  
 
2.1.4 Age 
Atherosclerosis progresses over a prolonged period. Over decades, this 
results in the gradual increase in width of the inner layers of arteries. It is the 
measurement of this phenomenon by ultrasound, the CIMT, which is the key 
aspect of the study discussed fully below. A healthy person reaches a CIMT 
of 0.78 mm at the age of 76 years3. The CIMT increases with advancing age 
in human as well as animal models of ageing24. 
The age-related increase in CIMT has always been thought to be due to 
atherosclerosis. However, there is now evidence that this may not be the 
case. One theory is that the increase in CIMT with age in healthy adults is an 
adaptive response of intrinsic compositional elements of the arterial wall to the 
chronic and progressive elevation in arterial blood pressure. The fact that 
resting brachial artery systolic and arterial pulse pressures increase with age 
in the general population and correlates with the age-associated increase in 
CIMT, is consistent with this concept. Findings in the study25 indicate: 
1. CIMT increases progressively with age in healthy normotensive men in 
the absence of elevations in peripheral SBP; 
                                                 
22
 Tell GS, Polak JF, Ward BJ, et al. 1994. 
23
 Haapänen A, Koskenvuo M, Kapiro J, et al. 1998. 
3
 de Groot et al 2004 
24
 Nagai Y, Metter EJ, Early CJ et al. 1998. 
25
 Tanaka H, Dinenno FA, Monahan KD et al 2001 
 13 
2. Carotid SBP also increases with advancing age and is positively 
associated with an increase in CIMT; 
3. The significant increase in CIMT with age is abolished after statistically 
accounting for the corresponding increase in carotid SBP. Carotid SBP 
was the only independent predictor of the age-associated increase in 
CIMT. 
Thus the literature indicates that CIMT is strongly and positively related to 
elevations in carotid SBP. Chronic increases in local distending pressure may 
be an important mechanism in the wall thickening of central elastic arteries 
that occurs with human ageing. 
 
2.2   ATHEROSCLEROSIS, CORONARY ARTERY DISEASE AND 
CAROTID INTIMA-MEDIA THICKNESS (CIMT) 
2.2.1  Atherosclerosis and CIMT 
The easy accessibility of the carotid arteries, due to their superficial location 
and size, makes them most suitable for study26.  
B-mode ultrasound assessment of CIMT provides measurements of arterial 
wall abnormalities and thus a non-invasive assessment of the degree of 
atherosclerotic change. Intense research has been done, and is ongoing, to 
assess the value of CIMT in complementing the established cardiovascular 
risk factors in predicting the outcome of cerebrovascular and coronary artery 
disease. 
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In its early stages, atherosclerosis is restricted mainly to the intimal layer of 
the vessel wall. Ultrasound does not allow for the distinction between the 
intimal layer and the medial layer. CIMT measurements are done on B-mode 
ultrasound, when the two echogenic (bright) lines, representing the lumen-
intima interface and the media-adventitia interface (intima-media complex), 
are visualized27. It is the thickness of the complex which constitutes the 
carotid intima-media thickness (CIMT). 
 
2.2.2  Accuracy and Reproducibility of CIMT Measurements 
Although studies have shown that ultrasound measurement of CIMT is a 
reliable surrogate marker for CAD, de Groot et al3 emphasised the need for 
standardised and strictly implemented imaging protocols in observational 
studies and clinical research, in order to exploit the full potential of ultrasound 
imaging. Trials tend to be multi-centred and large numbers of images are 
generated. Standardised protocols would minimise inter-scanner differences 
and contribute to the accuracy of image analyses. 
 
Earlier studies of the CIMT focused on the ultrasound measurement of the far 
wall of the common carotid artery intima-media complex only. It was found to 
be generally constant throughout the vessel and easily reproducible28. 
However, the most important objective of research in this field is the 
improvement of the accuracy and reproducibility of the measurements. This is 
particularly so for the precision required in assessing progression rates in 
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intervention studies29.  Design options and suitable ultrasound protocols are 
explored here. Questions raised include: 
• Which arterial segments should be examined? 
• Should measurements be taken at the near and far wall on the B-mode 
image? 
• Should one optimal angle be used or several images?  
• Should one use an automated measurement technique, or manual 
measurements the CIMT? 
It was concluded that the use of the mean maximum CIMT, using images from 
all segments, including the common carotid (CCA), the carotid bulb (BULB) 
and the internal carotid artery (ICA), yields more information and is favoured 
over the mean common CIMT only. Multiple images were thought to reduce 
measurement errors and increase precision. 
In terms of the measurements, automated edge detection systems work very 
well when there are clear interfaces on the ultrasound images. However, 
when there is an uneven margin created by focal plaque, manual 
measurements would be more advantageous. 
 
In my study protocol multiple measurements (12) were recorded and CIMT 
was measured manually, as discussed in detail under technique.  
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2.2.3  Value of CIMT in Coronary Artery Disease 
The impact of the known risk factors for CAD, namely hypertension, diabetes 
mellitus, hyperlipidaemia, cigarette smoking, age and gender on CIMT has 
been well established. However, the association between IMT and 
atherosclerosis of the coronary arteries, continues to be the subject of intense 
investigation8. The non-invasive, inexpensive, and reproducible features of 
ultrasound measurement of CIMT as a predictor of future cardiovascular 
events, makes it a valuable clinical tool26.  
 
O’ Leary et al, highlights the value of the CIMT and the contribution it makes 
when added to known risk factors, to identify people at risk for CAD. Already 
in 1986 the value of B-mode ultrasound was recognised, where ultrasound 
assessment of atherosclerosis in the aorta was compared to the 
measurements of an excised segment of the aorta. The CIMT as measured 
by ultrasound was the same thickness as that measured by light microscopy.  
From then on CIMT was recognised as a surrogate marker of 
atherosclerosis30. 
However, the value of CIMT as an independent predictor of coronary artery 
events was questioned. In earlier studies of vascular wall changes, the CIMT 
was not widely accepted as a predictor for atherosclerosis in the sub-clinical 
phase. Veller et al28 compared intima-media thickness (IMT) to the presence 
of risk factors and the arterial ultrasound score (AUS), a measure of large-
scale qualitative changes in the vessel wall, a sensitive indicator of 
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asymptomatic coronary artery disease and good predictor for the subsequent 
development of cardiovascular symptoms. IMT was assessed bilaterally in 
140 subjects who were symptom free, using the mean thickness of the 
common carotid artery (CCA) IMT. The mean IMT was linearly related to age, 
pack years of smoking, hypertension and to the arterial ultrasound score 
(AUS). The conclusion drawn from the study is that IMT, similar to AUS, is a 
predictor of risk for CAD. Smoking and hypertension were found to be 
significant contributors to increased IMT. However, limitations were 
experienced in the reproducibility of the IMT measurements, due to technical 
constraints, involving the resolution of the ultrasound beam. 
 
Subsequently, with the improvements in the high-resolution equipment, 
reproducibility of B-mode ultrasound imaging of the IMT is greatly improved. It 
is now widely accepted as an accurate and reliable method to predict 
cardiovascular events8 31 32, even with the use of different protocols. CIMT 
measurement errors have been minimised from 25-40% to 10-20%. Of 
importance, when compared with histology of arterial sections, measurement 
of far wall thickness by ultrasound was found to be a true measure of the 
arterial wall thickness27. 
Two publications arising from the Rotterdam study cohort, one of the largest 
studies to-date that used B-mode ultrasound to assess CIMT in a general 
population, are frequently sited in discussions around the evaluation of CIMT 
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as a tool to predict CAD outcomes and its relationship to the standard risk 
factors. 
The first was a cross-sectional study by Bots, Hoes, Hofman et. al, where 
CIMT was measured to estimate the individual 10 -12 year absolute risk for 
stroke, coronary artery disease and death33. The risk function for stroke and 
CAD was calculated based on information from the Framingham Heart Study 
and the Framingham Heart Cohort. Risk factors included for CAD were age, 
systolic blood pressure, total- to HDL-C ratio, left ventricular hypertrophy (on 
ECG), smoking and Diabetes Mellitus. They found a strong positive 
correlation between CCA CIMT and risk score. 
The authors conceded that increased CIMT may be of use to identify patients 
at high risk and therefore would be suitable to guide therapeutic decisions. 
However, they stated that the contribution CIMT makes in relation to other 
easily obtainable cardiovascular risk factors needs further evaluation. 
 
In the second study, reservations were expressed around the value of the 
CIMT as an independent predictor of CAD34. The study focused on CIMT 
(mean maximum) and its relationship to established risk factors, to determine 
the predictive value of CIMT in coronary disease and cerebrovascular 
disease. The data was obtained from a nested case-control study in the area 
of Rotterdam in the Netherlands and included 374 subjects who were 
diagnosed with CAD or stroke and 1496 controls. Regression analyses and 
the area under the receiver operating characteristic curve (ROC area) were 
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used to quantify the predictive value of the established risk factors and the 
added value of CIMT. 
The results showed a significant association between CIMT and risk of 
coronary artery disease and cerebrovascular disease. From their results, a 
single CIMT measurement (CCA in that study) does not add to the predictive 
value provided by the commonly used risk factors. The implication drawn was 
that CCA CIMT would not be more valuable as a screening method to identify 
patients at risk. 
In the words of Bots et al. (1999) cited above, ‘Quantitative information 
showing that increased intima-media thickness is related to long-term future 
cerebrovascular and cardiovascular disease is very limited but urgently 
needed’. 
 
In a more recent publication by Bots et al.29, the authors outline their planning 
for the use of CIMT in intervention studies. They favour the use of the mean 
maximum CIMT (from multiple sites) over the mean CCA CIMT (a single site). 
This was based on a review of several studies showing that the mean 
maximum CIMT measurements can be obtained in practically all subjects, in a 
reliable and reproducible manner. 
 
Ward Riley presented a challenge to the medical community in an editorial35, 
where he states that the use of CIMT has without doubt been shown to be a 
strong predictor of future cardiovascular events.  He quotes the work of del 
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Sol et al. cited above34 where the authors found that CIMT (using only the 
common carotid artery measurements) is nearly as predictive for CAD as all 
the traditionally accepted risk factors such as age, sex, previous MI and 
stroke, diabetes mellitus, smoking, systolic blood pressure and total HDL-C 
levels.  
Riley’s concern is that researchers may assume that any measured segment 
of the carotid artery would have the same predictive value for CAD. Most of 
the studies that I have referred to used only the common carotid artery 
segment, probably because it is easier. The reason that has been given 
though, is that there is less missing data as compared to the use of the other 
segments of the carotid artery. What must be remembered though, is that, to 
quote Riley, ”…atherosclerosis is a generalised disease that is 
circumferentially asymmetric...” The bulb tends to be the site where 
atherosclerosis begins.  From a scientific perspective, all three segments 
would yield more information and should therefore be used in order to gain 
maximum value from using CIMT measurements to predict CAD.  Riley’s 
challenge to us is stated in the following quote, “We owe it to the potential of 
carotid intima-media thickness that it not go the way of other diagnostic tests 
due to a lack of resolve to do it the right way…”  
 
In my dissertation the mean maximum CIMT is measured as the mean value 
measured at 12 sites. 
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2.2.4  CIMT and Angiographic Evidence of CAD 
The following two studies are of particular relevance to the study I have done. 
In the study of Geroulakos, Gorman, Kolodiki et al, the CIMT (CCA) was 
correlated with the extent of CAD found at angiography36. The study group 
consisted of 75 male subjects who had coronary angiography for assessment 
of angina, myocardial infarction or valvular disease. The control group 
consisted of 40 normal subjects who were matched for age and sex. 
Measurements of the CCA CIMT were done at the far wall, 2cm before the 
bulb.  A total of six measurements were taken (three on each side) and a 
single observer took all the measurements. 
No differences were found in the mean CIMT between controls and the group 
who had no coronary artery disease at angiography, CIMT for controls 
0.71mm, and for subjects with no coronary disease 0.73mm. A progressive 
increase in the CIMT was shown for groups with single vessel (0.91mm, 
p<0.05), two-vessel (0.96mm, p<0.01) and three vessel disease (0.99mm, 
p<0.01), with a linear trend of r=0.44 (p<0.00001). 
After correction for age, a cut-off point of .85mm was taken to predict severe 
CAD, with a high positive predictive and specificity value. The conclusion they 
drew was that a combination of high specificity and high negative predictive 
values, makes the CIMT a useful screening test in a population with a low 
prevalence of CAD.   
 
In the second pertinent study, the relationship of CIMT and CAD was 
analysed in a large group of 558 subjects in Poland, with a mean age 58.8 
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(SD 9.2) years8. All subjects in the study group were suspected of having 
CAD on admission to the department: most of them had a positive treadmill 
test, segmental hypokinesis or akinesis on echocardiography, ischaemic 
changes on ECG, or symptoms suggesting angina of Functional Class II or 
more. Notwithstanding these clinical features, 17% of the subjects had no 
coronary artery lesions. 
The coronary angiography results indicated the following: 
1. 95 pts (17%) had normal coronary arteries; 
2. 154 pts (27.6%) had one vessel CAD; 
3. 104 pts (18.7%) had two vessel CAD; 
4. 205 pts (36.7%) had three vessel CAD. 
The changes in mean CIMT were correlated with known risk factors, including 
age, sex, hypertension, diabetes, hyperlipidaemia and cigarette smoking. 
These findings establish the value of CIMT as an independent risk factor for 
CAD. 
Their results identified four independent predictors of CAD: 
• Age (p=0.0193); 
•  Hyperlipidaemia (p=0.0001);  
• Smoking (p=0.0032);  
• CIMT (p<0.0001). 
The theoretical distributions of CIMT showed that patients with a mean CIMT 
over 1.15mm had a 94% probability of having CAD, with a sensitivity of 65% 
and specificity of 80%. 
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The conclusions they arrived at was that CIMT increases with advancing age, 
increases in the CIMT have a high and specific likelihood of CAD and that 
ultrasound examination of the carotid arteries can effectively predict 
atherosclerosis of the coronary arteries. 
 
2.3   Conclusions from the Literature 
Hypertension is the most significant risk factor for MI in Black South Africans.   
There is great enthusiasm amongst all researchers to find non-invasive 
methods for identifying people at risk for coronary artery disease, particularly 
where therapy can prevent adverse outcomes in atherosclerosis.  
B-mode ultrasound has been accepted as safe and accurate and most of all, 
relatively inexpensive as a method for investigating atherosclerosis in its 
subclinical phase. Young people can now be included in multi-centred trials, 
because ultrasound is safe and non-invasive.  
The use of standardised protocols for imaging and measuring CIMT will 
enhance the accuracy and thereby the predictive power of CIMT. This is 
particularly important in intervention studies, where accuracy and 
reproducibility of CIMT measurements would be critical, so that the efficacy of 
interventions could be more precisely assessed. 
There is clear evidence of a positive correlation between CIMT and risk 
factors and CIMT and consequently CAD. There is growing support for CIMT 
as an independent predictor for CAD.  
More research is needed, especially in South Africa, to support the use of B-
mode ultrasound measurements of the CIMT as a surrogate marker for CAD, 
in view of the increasing incidence of CAD in the Black population.  
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3   THE STUDY 
3.1 AIM OF THE STUDY 
To determine the value of ultrasound measurements of carotid intima-media 
thickness – CIMT, as a surrogate marker for coronary artery disease, in the 
South African Black population. 
3.2  OBJECTIVES OF THE STUDY 
To compare Ultrasound measurements of CIMT in: 
I. A study group of South African Black subjects with evidence of 
coronary artery disease on coronary angiography. 
II.  A control group of South African Black subjects with no evidence of 
coronary artery disease on coronary angiography. 
A sub-group analysis was done in groups I and II to assess: 
A. The presence of factors which constitute the Metabolic Syndrome as 
defined by the IDF:  
                a) Central Obesity: waist circumference >94 cm for men and > 80        
   cm for women; Plus any 2 of the 4 factors below 
            b) Raised TG level: > 1.7 mmol/L; 
     c) Reduced HDL-C: <1.03 mmol/L in men <1.29 mmol/L in women  
         or specific treatment for these lipid abnormalities; 
                 d) Raised BP: systolic BP >130, or diastolic BP >85 mmHg or   
                     treatment of previously diagnosed hypertension; 
                 e) Raised fasting plasma glucose: >5.6 mmol/L or previously  
                     diagnosed Type 2  
B. Other risk factors such as smoking, LDL-C and increasing age. 
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3.3 ETHICAL CLEARANCE:  
University of the Witwatersrand Ethical Committee PRC 010 102 (See 
Appendix 1.)  
 
3.4 INFORMED CONSENT 
The attending physician obtained informed and written consent from every 
patient. The aims of the study, the rationale for all investigations and 
procedures and their voluntary participation was fully explained and 
formally agreed to. 
 
3.5  HYPOTHESES 
It was hypothesised that: 
I. There will be a positive correlation between an abnormal CIMT 
measurement and the presence of coronary artery disease; 
II.  The factors which constitute the Metabolic Syndrome would have a 
positive correlation with an increase in CIMT; 
III.  The measurement of the CIMT would be a useful marker for CAD 
in the Black population of South Africa. 
 
      3.6  STUDY DESIGN, SETTING AND PROTOCOL 
  This was a prospective study in which the study population and the    
  controls had undergone coronary angiography, and have had B-mode    
  ultrasound to assess CIMT. 
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3.6.1 Study Population 
3.6.1.1 Recruitment 
Patients of both the study and control groups were recruited from the Cardiac 
Clinics of the Chris Hani Baragwanath, Helen Joseph and Johannesburg 
Hospitals.  
The research population consisted of a total of 53 subjects of the age group 
30-70 years including: 
o Study group: 38 
o Control group: 15 
 
3.6.1.2  Criteria for Recruitment  
The Study group were recruited on the basis of confirmed CAD at 
angiography - defined as lesions greater than 50% in one or more of the 
major coronary vessels. Subjects with a previous myocardial infarction had to 
be at least 3 months post-infarction before recruitment. 
The Control group were patients who were suspected of having CAD, 
recruited on the basis of normal coronary arteries at angiography. 
 
3.6.1.3  Exclusion Criteria 
I. Subjects who were previously diagnosed with diabetes mellitus (DM) or 
genetic dyslipidaemia; 
II. HIV-positive subjects; 
III. Subjects who smoked >20 cigarettes per day; 
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IV. Subjects with overt renal, thyroid or liver disease; 
V. Subjects where the imaging circumstances were very poor, with limited 
boundary visualization or where there were anatomical constraints, 
either a high carotid artery bifurcation or a short thick neck, where more 
than 2 segments were not visualized. 
 
3.6.2  Ultrasound Setting 
Ultrasound imaging was carried out at the Johannesburg Hospital by the 
candidate sonographer who holds a certificate in CIMT imaging from the 
Julius Centre in the Netherlands. This kind of training has vastly improved the 
technique and no doubt, the accuracy and reproducibility of the CIMT 
measurements.  
To obtain certification, video recordings of the entire procedure of the 
designed protocol had to be regularly submitted to the Julius Centre for 
assessment, until certification. All certification scans were done on volunteers.  
Ongoing certification also requires the submission of monthly video recordings 
for the purposes of quality control. 
The candidate sonographer was blinded to both the coronary angiography 
and clinical results until the end of the ultrasound studies on all the subjects. 
 
3.6.3  Ultrasound Protocol 
3.6.3.1  Imaging Instrumentation 
I. High resolution B-mode ultrasonography was used; 
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II. All Scans were carried out using a single ultrasound machine: Toshiba  
System: Nemio Model SSA-550 A; 
III. The transducer frequency was set at 11MHz for all patients (preset for 
the carotid programme). 
 
3.6.3.2  Technique   
I. Ultrasound imaging procedures were standardised for all subjects, 
using the same protocol; 
II. The subject lies supine with the sonographer sitting at the head-end. 
The ultrasound machine is located to the left of both the patient and 
the sonographer. The head is slightly extended and turned 35 
degrees to the contra-lateral side; 
III. Scanning is commenced by holding the transducer in the transverse 
plane and then sliding it from above the clavicle, to the area of the 
bifurcation of the carotid artery. Identification of the thyroid gland 
medial to the vessels, and the internal jugular vein which is 
compressible, helps to identify the CCA;  
IV. At the carotid bifurcation, the ECA and ICA are identified and 
depending on the position of these vessels in relation to each other, 
the optimal angle is selected, according to the technique taught at the 
Julius Centre. Selection at the optimum angle of interrogation (OAI), 
allows the visualization of the flow tip divider, which is the echogenic 
interface between the ICA and external carotid artery (ECA), the 
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CCA, BIF and ICA, in a single selected angle of the carotid arteries at 
the bifurcation; 
V. The transducer is then placed longitudinally on the neck at the OAI 
where the CCA, BIF, ECA and ICA can be easily identified. Doppler is 
used to verify the identification of the ECA and ICA; 
VI. The intima-medial thickness (IMT) was measured when the two 
echogenic lines, representing the lumen-intima interface and the 
media-adventitia interface, are visualized over a length of ≥1cm. The 
segment should be clear of calcified plaque, which obscures the lines 
and thereby obstruct the measurement of the IMT; 
VII. Measurements of the IMT were done manually, using the calliper 
markers of the ultrasound unit (electronic measurement facilities are 
not available on the ultrasound machine used); 
VIII. The IMT at the optimal angle of interrogation was measured, as the 
area of maximum thickness at the near and far walls of the CCA, BIF 
and ICA bilaterally (a total of 12 sites). In cases where calcific plaque 
obscured the IMT in the bulb, one wall was measured;  
IX. The thickest measurement in each segment was imaged and 
recorded as the final measurement. The mean maximum IMT was 
recorded as the CIMT; 
X. Images were stored on a magnetic optical disc as well as on thermal 
paper. 
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The following four figures depict the ultrasound images which were used 
when measuring the CIMT: 
• Figure 3.1: Shows an image of the carotid artery selected at the 
optimal angle. All the segments included in the scanning 
protocol, namely, the CCA, BULB and ICA are demonstrated in 
a single view; 
• Figure 3.2: Shows an image of the common carotid segment; 
• Figure 3.3: Shows an image of the bulb or bifurcation; 
• Figure 3.4: Shows an image of the bulb and the internal carotid 
artery.  
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FIGURE 3.1  ULTRASOUND IMAGE OF THE CAROTID ARTERY 
                     SELECTED AT THE OPTIMAL ANGLE 
BULB ECA 
ICA 
NEAR WALL 
FAR WALL 
CCA 
The six segments that were measured are shown: 
• CCA: Common Carotid Artery near and far wall 
• Bulb or Bifurcation: Near and far wall 
• ICA: Internal Carotid Artery near and far wall 
Also seen are: 
• FTD: Flow Tip Divider: Echogenic interface between the Internal and 
External 
           Carotid Arteries which is the landmark that identifies the Bulb 
• ECA: External Carotid Artery (not used for measurements). 
FTD 
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FIGURE 3.2  ULTRASOUND IMAGE OF THE COMMON CAROTID 
ARTERY 
                  
The caliper – A is positioned at the point where the distance between the 
                      parallel lines – the Intima-media of the far wall is measured 
   
CC
NEAR 
FAR 
• The measurement of 0.8mm is the cut-off point for normal 
   Intima-media width in my study. 
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FIGURE 3.3  ULTRASOUND IMAGE OF THE COMMON CAROTID 
ARTERY AND THE BULB 
The caliper – A is positioned at the point on the far wall where the width  
between the parallel lines - the Intima-Media is measured 
  
 CC
NEAR 
 
FAR 
BUL
• The measurement of 1.0mm is increased Intima-Media thickness 
   in my study. 
33 
 34 
 
FIGURE 3.4  ULTRASOUND IMAGE OF THE BULB AND INTERNAL 
CAROTID ARTERY 
The caliper – A is positioned at the point on the far wall of the Internal  
                      Carotid Artery where the distance between the parallel lines –  
                      the Intima-Media is measured 
 
 The measurement of 0.9mm is increased Intima-Media  
                            thickness in my study.  
IC BUL CC
NEAR 
FAR 
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3.7 DATA COLLECTION  
Data on the clinical and biochemical risk factors, including those for the 
Metabolic Syndrome (MS) was provided from pooled patient information of a 
parallel study entitled “Coronary Artery Disease in Black South Africans”, 
using the same cohort37. 
After exclusion of known diabetics, all subjects were tested for fasting blood 
glucose and glucose tolerance tests were done to identify subjects with 
abnormal glucose metabolism. 
 
3.8   THE DATA ANALYSIS 
3.8.1   The Carotid Mean Maximum Intima-Media Thickness (CIMT) 
Measurements 
The CIMT was calculated as the average for 12 sites for all subjects, using 
the Excel programme for Windows XP. 
Mean values for the CIMT > 0.8mm were classified as increased thickness. 
The work of de Groot et al3 was used as the basis for the criterion for 
increased CIMT thickness in my study. They used a standard protocol for 
predicting progression rates for CIMT and concluded that the normal growth 
rate of CIMT is up to 0.78mm at the age 76 years. They also demonstrated 
that increases in the CIMT correlated with the known risk factors. 
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3.8.2 Statistical Methods 
Besides the control- and study populations based on the absence or presence 
of CAD at angiography, those with CAD were divided into three groups, in 
accordance to the number of coronary vessels involved at angiography: one-
vessel, two-vessel or three-vessel involvement. 
The Excel programme for Windows XP was used to calculate the mean 
maximum IMT (CIMT) of the carotid arteries. To assess the independent 
value of the CIMT as a predictor of CAD, linear and multiple regression 
analyses were done, using the GB –STAT for Windows, Version 10, Dynamic  
Microsystems Inc. 2004. 
 
3.9 RESULTS 
Among the 53 participants (41 men and 12 women) the coronary angiography 
results showed that 15 people had no evidence of CAD. This constitutes the 
Control group. The Study group was constituted of the 38 subjects with 
evidence of CAD. 
The discussion of the results will firstly consider the Control group.  Following 
on this, there will be comparisons between the Study and Control groups.  
The Study group will then be fully discussed in terms of all the risk factors. 
Selected graphs will be included. 
NB Hypertension was the dominant feature in this study. The impact of 
hypertension on the development of atherosclerosis and thus on the CIMT, is 
well established. In addition, all the study subjects, except for one individual, 
were hypertensive and thus its effect separate from that of other risk factors 
affecting the CIMT could not be assessed.  
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3.9.1   THE CONTROL GROUP 
Of the 15 subjects, there were ten males and five females, a ratio of 67% to 
33% females. The mean age was 47 years, with an age-range of 30-65 years. 
8 of the 15 (53%) had increased CIMT. The mean CIMT was calculated as 
0.998.  
The proportions of risk factors for the Metabolic Syndrome in the group were: 
• Increased abdominal circumference: 33.3%; 
• High blood glucose level: 13.3%; 
• High Triglycerides : 26%; 
• Low HDL-C: 33.3%; 
• Hypertension: 60%; 
Of the other risk factors: 
• High LDL-C (defined as an LDL-C ≥ 3.4 mmol/L): 13.3%; 
• Smokers and ex-smokers were categorised as smokers:  20%. 
Of interest amongst the controls, is that three of the 5 females, aged 47, 52 
and 64 years (none of them smokers), had evidence of the Metabolic 
Syndrome and correspondingly, increased CIMT: 
• The CIMT for the 47 year old was 0.93 mm, for the 52 year old it was 
1.03 mm and for the 64 year old it was 1.56; 
• These subjects are all at risk for CAD. The outcome for the last subject 
having a very high value for CIMT is of particular concern, and close 
clinical follow-up is indicated. 
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3.9.2  COMPARISON OF PROFILES OF THE STUDY GROUP AND THE 
CONTROL GROUP 
The comparison of the profiles of the control group with the study group are 
shown in Table 3.1 
 
TABLE: 3.1   PROFILES OF CONTROL AND STUDY 
POPULATIONS 
 
 CONTROLS 
STUDY 
POPULATION 
   
RATIO: % M:F 67M     33F 77M     23F 
MEAN AGE (YEARS) 47.00 55.00 
MEAN INTIMA-MEDIA THICKNESS (CIMT) 1.00 1.13 
% OF SUBJECTS WITH INCREASED CIMT 53.00 76.00 
   
MEAN LEVEL OF TG 1.38 1.88 
% RAISED TG (> 1.7mmol/L) 26.70 50.00 
   
% LOW HDL-C (M: <1.03; F: <1.29) 33.33 42.10 
   
MEAN LEVEL OF LDL-C 2.65 3.28 
% RAISED LDL-C (>3.4mmol/L) 13.33 42.11 
   
MEAN LEVELS OF FASTING BLOOD GLUCOSE 4.33 5.23 
% RAISED FASTING BLOOD GLUCOSE 
    (> 5.6mmol/L) 13.33 15.79 
% DOCUMENTED DIABETIC / IMPAIRED 
    GLUCOSE METABOLISM    0 55.26 
   
% OBESE (ABDOMINAL CIRCUMFERENCE BY 
    EUROPEAN CRITERIA) 33.33 79.17 
   
% HYPERTENSIVE 60.00 97.00 
   
% SMOKERS OR EX-SMOKERS 20.00 62.50 
 
 
The most pertinent difference was in terms of the CIMT. The average CIMT of 
the Study group was higher, 1.13 compared to 1.00 for the Control group and 
a higher percentage of the Study group had an increased CIMT (76%) than 
the Control group (53%). When examining for reasons for these differences, 
the data demonstrate that: 
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• The Study group mean age (55 yrs) was higher than the Control group 
(47 yrs); 
• There were more males in the Study group than in the Control group 
(67% vs. 77%); 
• In the Study group 79.17% of subjects were classified as obese, with 
33.33% in the Control group; 
• The Study group had a higher percentage diagnosed as hypertensive 
(97%) than the Control group (60%); 
• The percentage of subjects with high fasting blood glucose was 15% 
for the study group and 13.33% for the controls; 
• The proportion of subjects with high triglyceride levels were higher in 
the Study group (50%) compared to the Control group (26.7%);  
• In the Study group the percentage of people with low HDL-C (42%) 
was higher than in the controls (33%); 
• The proportion with raised LDL-C levels was higher in the Study group 
(42%) than for the controls (13.33%); 
• Smokers in the Study group constituted 62.5% whereas only 20% were 
smokers or ex-smokers in the Control group. 
Clearly, the Study group is characterised with a greater burden of all the 
known risk factors for CAD: the factors constituting the Metabolic Syndrome 
and the other two risk factors considered in my study, age and smoking. 
These features support the hypothesis that increased CIMT has a positive 
relationship with risk factors as well as with CAD as proven at angiography.  
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3.9.3   STUDY GROUP 
In general, in the study population 29 of the 38 subjects had increased CIMT - 
76%, with an average MIMT of 1.13mm. In the sections that follow, each of 
the specific risk factors for CAD are correlated with the changes in the CIMT. 
. 
3.9.3.1  AGE 
The mean age for the Study group was 55.4 years, with the ages ranging from 
36 to 69 years. Linear regression analysis for CIMT against age (see 
Addendum) shows that increasing age is related to increased CIMT 
(Correlation Coefficient =.223, p= 0.17). The graph in Figure 3.5 depicts the 
linear regression trend. These findings support the findings in previous 
studies8 38 39. 
FIGURE  3.5  RELATIONSHIP OF CIMT WITH AGE 
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3.9.3.2  GENDER 
The Study group consisted of many more males than females, 31 males and 
7 females. The average CIMT for males (1.178) was higher than for the 
females (0.91). 
The risk factor profile for CAD, other than age, where the women were older, 
(59 yrs vs. 55 yrs), was greater in males, both in terms of the IDF definition of 
the MS: obesity, hypertension, increased fasting glucose, high triglyceride 
levels and low HDL-C levels, as well as for the additional risk factors explored 
in this study, high LDL-C levels and smoking: none of the women smoked. 
Table 3.2 below depicts the differences in the two groups.  
TABLE 3.2   COMPARISON OF FEMALES 
 WITH MALES OF THE STUDY 
 GROUP FEMALES 
           
MALES 
NUMBERS  7 31 
AVERAGE AGE 59 55 
CIMT 0.91 1.18 
NUMBER WITH INCREASED CIMT 5 24 
              % 71.43 77.42 
NUMBER WITH INCREASED GLUCOSE 2 7 
              % 28.57 25.81 
MEAN BLOOD GLUCOSE VALUE 5.6 5.17 
NUMBER WITH ABNORMAL GLUCOSE METABOLISM 5 16 
              % 71.43 51.61 
OBESITY 5 17 
              % 71.43 54.84 
NUMBER WITH INCREASED TG 4 15 
              % 57.14 48.39 
NUMBER WITH LOW BLOOD HDL-C 3 12 
              % 42.86 38.71 
NUMBER WITH INCREASED BLOOD LDL-C 4 11 
              % 57.14 35.48 
NUMBER WITH HYPERTENSION 7 30 
              % 100 96.77 
NUMBER WITH THE METABOLIC SYNDROME (MS) 5 15 
              % 71.43 48.39 
              NUMBER WITH INCREASED CIMT 3 12 
              % 42.86 80 
              AVERAGE CIMT  1.00 1.244 
SMOKERS 0 16 
              %  51.61 
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The risk profile for males is clearly higher in this study. These findings are 
similar to those of Oren et al31. However, the number of participants was 
much larger in their study. Future research on larger groups in the South 
African Black population needs to be done, for better evaluation of gender 
differences. 
 
3.9.3.3  THE METABOLIC SYNDROME 
Of the subjects with the MS, a higher percentage had increased CIMT when 
compared with the whole Study group (87.5% vs. 76%). These features are 
shown in Tables 3.1 and 3.3 and Figure 3.6. These findings support previous 
studies38 40 which showed a similar trend, where CIMT was shown to be 
higher in subjects with the MS as compared to controls and that the MS is 
independently associated with an increased CIMT. 
However, subjects without the MS also have a high percentage with an 
increased CIMT, 72.73%. As can be seen in Figure 3.6, the percentile scores  
for the CIMT values for those with the MS and those without the MS are 
virtually identical with median values of 1.07 and 1.09 respectively. 
TABLE: 3.3  CORRELATION OF INCREASED CIMT IN THE      
PRESENCE OF THE METABOLIC SYNDROME 
ACCORDING TO THE INTERNATIONAL DIABETES 
FEDERATION DEFINITION 
 NUMBER % 
NUMBER OF SUBJECTS WITH METABOLIC 
SYNDROME ACCORDING TO THE IDF DEFINITION 16 42.11  
    
INCREASED CIMT 14 87.5 
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FIGURE 3.6  CIMT IN CAD WITH- AND WITHOUT THE METABOLIC       
SYNDROME 
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All of those who had increased CIMT without the MS (IDF classification) had 
hypertension. In four subjects hypertension was the only other risk factor. The 
remaining subjects had hypertension and one or two of the risk factors for the 
MS.  These features are shown in Table 3.4. This supports the study, that 
hypertension is the most important risk factor for CAD in the South African 
Black population6. 
 
                                                 
6
 Steyn et al. 2005 
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3.9.3.3.1  HYPERTENSION 
The effect of hypertension on the incidence of coronary artery disease in the 
Black population as described1 is evident in this study. As stated before, all 
the subjects (37) but one in the Study population had hypertension. The 
individual without hypertension had a very low CIMT of 0.5. He had raised TG 
and low HDL-C levels. 
The effect of hypertension on CIMT has been shown in several papers23 40 
and its dominant effect is demonstrated in Figure 3.7, where the graph of the 
values for CIMT of those patients of the group who had not fulfilled the criteria 
for the MS but had hypertension as the only risk factor, is superimposed on 
the graphic illustration of the CIMT values of subjects with- and without MS in 
Figure 3.6. The median percentile value of 1.22 is greater than that for both 
MS and non-MS groups (1.07 and 1.09 respectively). 
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TABLE 3.4     CIMT VALUES FOR SUBJECTS WITH CAD WHO DO NOT 
 FULFILL CRITERIA FOR THE METABOLIC SYNDROME 
 
ENTITIES NUMBER AVERAGE CIMT  
(IN DESCENDING 
ORDER) 
HYPERTENSION, INCREASED FASTING       
GLUCOSE, LOW HDL-C 
 
1 
 
1.65 
HYPERTENSION 4 1.43 
HYPERTENSION, INCREASED TG 3 1.33 
HYPERTENSION, OBESITY 8 1.11 
HYPERTENSION, LOW HDL-C 2 0.96 
HYPERTENSION, INCREASED TG, 
                               LOW HDL-C 
 
3 
 
0.77 
INCREASED TG, LOW HDL-C 1 0.50 
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FIGURE 3.7  EFFECT OF HYPERTENSION ON CIMT 
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The figure above shows the effect of hypertension alone on the CIMT. The 
markedly increased range of percentile values in subjects with hypertension 
as the only risk factor for CAD indicates its profound effect on the CIMT. The 
major impact of hypertension on the structure and function on arteries has 
been documented in previous studies40, and in this study it probably affects 
every CIMT measurement of the study subjects. A larger matched study of 
subjects with- and without hypertension is essential, in order to fully document 
its effect on the CIMT and to document the effects of the other risk factors free 
of the effects of hypertension on the CIMT. 
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 Czernichow et al. 2005 
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3.9.3.3.2  OBESITY 
On analysis of the whole Study group, an increase in CIMT was found in 24 
subjects, who were classified as obese, as indicated by their abdominal 
circumference. Of the obese patients, 79.17% had increased CIMT. However 
the non- obese subjects had a similar proportion with increased CIMT 
(78.57%). These features are shown in Table 3.5.  
Linear regression analysis of CIMT against abdominal circumference of only 
the obese subjects shows a linear relationship of increasing abdominal 
circumference and increasing CIMT, with a Correlation Coefficient of 0.30, 
(p=0.15). This is demonstrated in Figure 3.8  
 
 
TABLE: 3.5    OBESITY AS INDICATED BY EUROPEAN 
     CRITERIA USING ABDOMINAL CIRCUMFERENCE 
     (M:>94 F: >80) 
 
 NUMBER % 
NUMBER WITH INCREASED ABDOMINAL 
CIRCUMFERENCE 24  
               % OBESE WITH INCREASED CIMT  79.17 
   
NUMBER WITHOUT INCREASED ABDOMINAL 
CIRCUMFERENCE 14  
               % NON-OBESE WITH INCREASED CIMT  78.57 
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From the results of my study, obese and non-obese subjects had similar 
percentages of increased CIMT. The findings were different in a study done 
within the population of the USA15 where obesity was found to be the 
dominant factor affecting the CIMT. What Opie and Seedat7 have pointed out, 
is that there is a clear relationship between the degree of obesity and blood 
pressure in South African Blacks.  
The effect of hypertension on CIMT in non-obese patients needs to be 
clarified in future studies. 
 FIGURE 3.8  LINEAR REGRESSION ANALYSIS OF CIMT AGAINST  
                                 ABDOMINAL GIRTH IN OBESE SUBJECTS 
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3.9.3.3.3   FASTING GLUCOSE  
The most significant finding here, is that all the patients with a raised fasting 
glucose had increased CIMT (100%). 
Of the patients who were found to have impaired glucose metabolism on 
glucose tolerance tests, 76.2% had increased CIMT.  However, those with 
normal glucose metabolism (neither raised fasting blood glucose nor an 
abnormal glucose tolerance test) had a similar percentage of subjects with 
increased CIMT, 76.4%. These values are shown in Table 3.6 and the linear 
regression model for CIMT against fasting blood glucose levels in Figure 3.9 
        
On simple linear regression analysis of the CIMT values against the fasting 
blood glucose levels, (see Addendum) there is good correlation of increased 
CIMT with raised fasting glucose levels (Correlation Coefficient of .35 and p = 
.03).  
 
Thus in this study, high fasting glucose levels are an important factor in 
causing increased CIMT and an important component of the MS in the South 
African Black population.  
TABLE: 3.6    GLUCOSE METABOLISM OF STUDY POPULATION 
 NUMBER % 
RAISED FASTING BLOOD GLUCOSE (> 5.6) 6.00   
                % WITH INCREASED CIMT   100.00 
   
DOCUMENTED DIABETIC / IMPAIRED GLUCOSE 
METABOLISM 21.00   
                % WITH INCREASED CIMT   76.20 
   
NORMAL GLUCOSE METABOLISM 17.00   
                % WITH INCREASED CIMT  76.47 
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What needs further study is the finding that subjects with impaired glucose 
metabolism as indicated by an abnormal glucose tolerance test have a 
proportion of subjects with increased CIMT which is no different to that for 
subjects with normal glucose metabolism. The possibility of a marked and 
overriding effect of hypertension in the subjects with normal glucose 
metabolism needs to be investigated. 
A study done by Tropeano AI, Boutouyrie P, Katsahain S et al41 showed that 
fasting glycaemia had a strong influence on CIMT in subjects who were 
hypertensive and had impaired fasting glucose (IFG).  The aim of the study 
was to determine the influence of fasting glycaemia on CIMT in hypertensive 
subjects with either normal fasting glucose, impaired fasting glucose (IFG) or 
Type 2 diabetes (DM-2). The study population consisted of 158 subjects with 
essential hypertension, with either normal fasting glucose (n=74), IFG (n=24) 
or DM-2 (n=60). The CCA was used to assess the CIMT. The results showed 
that the CIMT of subjects with DM-2 were significantly higher than that of 
subjects with IFG and normal glucose. Using multivariate analysis, the results 
showed that in subjects with normal fasting glucose, blood pressure and age 
were the major determinants of CIMT and glycaemia was not. However in 
subjects with IFG or DM-2, fasting hyperglycaemia was strongly associated 
with increases in CIMT and blood pressure was not. 
Their conclusion was that hyperglycaemia is the major determinant of 
increased CIMT in the presence of hypertension, already at the IFG stage 
(before the onset of frank diabetes), and in fact overrides the effect of 
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 Tropeano AI, Boutouyrie P Katsahia S et al 2004. 
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hypertension on the CIMT. They suggest that this indicates a need for early 
institution of anti-diabetic therapy. 
Some aspects of my study support their conclusions: 
• Similarly to Tropeano et al, 100% of patients with high fasting glucose 
had increased CIMT, supporting the notion that high fasting glucose 
levels have an overriding effect on CIMT in patients with hypertension; 
• The increased CIMT in 76.47% of subjects with normal fasting glucose 
and normal glucose tolerance tests is likely due to the dominant effect 
of hypertension on the CIMT. 
However, my study has shown that the subjects with abnormal glucose 
metabolism (including those with high fasting blood glucose levels) as 
indicated by abnormal glucose tolerance tests, have a proportion (76.20%) 
with high CIMT, which is no different from those without this abnormality.  
This suggests that in South African Blacks, hypertension remains the 
dominant risk factor for CAD, even in the face of abnormal glucose 
metabolism, until the stage of high fasting blood glucose. Clearly, a larger, 
carefully controlled study in this population is required to confirm this and to 
evaluate the proposal for early institution of anti-diabetic therapy for subjects 
with hypertension, as suggested by Tropeano et al.   
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FIGURE 3.9  RELATIONSHIP OF CIMT WITH FASTING BLOOD 
                     GLUCOSE LEVELS 
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3.9.3.3.4   BLOOD LIPIDS 
The lipid components that form part of the Metabolic Syndrome are the blood 
triglycerides (TG) and HDL-C levels. 
There were 19 patients who had raised TG levels and 78.95% had increased 
CIMT, which is expected. However the percentage with increased CIMT was 
similar in the 19 subjects with normal triglyceride levels (73.68%).  The 
question of hypertension causing the increased CIMT needs to be 
investigated. 
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In the correlation with HDL-C levels, the CIMT values were higher in the 
subjects with normal to increased levels (81.81%), whereas only 68.75% of 
the 16 subjects with low HDL-C levels had increased CIMT. These findings 
cannot be fully explained. Further investigation on larger groups need to be 
carried out to determine the role of HDL-C in South African Blacks who are 
free of hypertension.  
 
These results are shown in Table 3.7. 
 
TABLE 3.7    LIPID PROFILE OF STUDY POPULATION 
 
 NUMBER % 
NUMBER WITH TG >1.7 19  
               % WITH INCREASED CIMT  78.95 
   
NUMBER WITH NORMAL TG LEVELS 19  
               % WITH INCREASED CIMT  73.68 
   
NUMBER WITH LOW HDL-C (M: <1.03; F: <1.29) 16  
               % WITH INCREASED CIMT  68.75 
   
NUMBER WITH NORMAL / HIGH HDL-C 22  
               % WITH INCREASED CIMT  81.81 
   
NUMBER WITH LDL-C ≥ 3.4mmol/L 16  
               % WITH INCREASED CIMT  93.75 
   
NUMBER WITH NORMAL LDL-C 22  
               % WITH INCREASED CIMT  63.64 
 
 
Although LDL-C levels are not included in the classification of the MS, the 
correlates of CIMT with LDL-C in my study show findings more in keeping with 
the role of dyslipidaemia. Subjects with high LDL-C levels had increased 
CIMT in 93.75% of cases. Of the subjects who had normal LDL-C levels, 
63.64% had increased CIMT. These findings support the “Response-to Injury” 
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theory12 which was put to the test in the study of Sun et al, as cited in the 
literature review14, which proposes that hypertension causes arterial wall 
damage, allowing high LDL-C levels to deposit in the intima-media, resulting 
in atherosclerotic changes.  
 
3.9.3.4  SMOKING  
The percentage of subjects who were smokers and had increased CIMT and 
non-smokers who had increased CIMT were similar, 75% and 77.27% 
respectively. The CIMT percentile values were similar, with median percentile 
values of 1.09 and 1.05 respectively. These are shown in Table 3.8, with the 
graphs in Figure 3.10  
 
TABLE   3.8   PERCENTILE CIMT VALUES OF SMOKERS AND 
    EX-SMOKERS VS. NON-SMOKERS 
 
SMOKERS AND EX-
SMOKERS 
NON-SMOKERS 
MEDIAN CIMT 
1.14 1.12 
25th PERCENTILE 
0.8 0.82 
75th PERCENTILE 
1.48 1.28 
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 FIGURE 3.10  CIMT IN SMOKERS VS. NON-SMOKERS 
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These results are similar to studies which provide evidence for the increased 
CIMT11 21 associated with smoking as an independent risk factor for CAD. The 
limitation of my study was that it was not designed to test for smoking as an 
independent risk factor. Also, it needs to be restated that the overwhelming 
effect of hypertension is probably interfering with the demonstration of the full 
effect of smoking in this study. 
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3.9.3.5 MOST SIGNIFICANT RISK FACTORS CONTRIBUTING TO 
            INCREASED CIMT 
The outcome of multi-variant analysis of CIMT against the individual risk 
factors is shown in Table 3.9.   
 
TABLE 3.9  MULTIVARIANT REGRESSION ANALYSIS 
                           
Dependent Variable: MIMT 
Multiple R  =  .5524 
Std Err Est =  .3686 
F  =  2.2692 
 
Ind Var                       B Coef Std Err(B) t-Value                       Prob 
AGE .003387                     .008029                           .4219                         .676 
GLUCOSE .213177                     .085904                           2.4816                        .0187 
GIRTH   -.009339                    .006113                          -1.5277                       .1367 
TRIGLYC -.081728 .07444                            -1.0979                       .2807 
HDL .362041                    .22524                              1.6074                      .1181 
LDL   .057634                    .063191                  .9121                       .3688 
 
Constant  .272124 
 
 
 
Hypertension was not included in this table as its dominant effect was clearly 
evident in the data presented. Of the other risk factors, fasting glucose levels 
was the closest correlate with increased CIMT values (p=0.02). Age and LDL-
C levels also showed a positive correlation. The positive HDL value is 
inconsistent with its protective role in the pathogenesis of atherosclorosis. 
 
3.9.3.6  RELATIONSHIP OF CIMT WITH  CORONARY  ANGIOGRAPHIC 
             FINDINGS 
The angiographic findings within the Study population showed that 12 people 
had single-vessel, 11 people had two-vessel and 12 people had three-vessel 
CAD at angiography.  Note that data regarding the number of vessels 
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involved for three of the patients who had confirmed CAD could not be 
located. 
The CIMT values of the control (no CAD) and three study groups are depicted 
in Figure 3.11 below. 
 FIGURE 3.11  CIMT WITH EXTENT OF VESSEL INVOLVEMENT  
CIMT
NO CAD 1 VES 2 VES 3 VES
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PERCENTILE CIMT VALUES IN CAD
 
The above graph indicates a correlation of the CITM and the extent of CAD: 
The median percentile scores show a progressive increase as the number of 
vessel involvement increases: 
• No CAD (control subjects)   Median = 0.93; 
• Single coronary vessel involvement  Median = 0.88; 
• Two coronary vessel involvement  Median = 1.08; 
• Three coronary vessel involvement  Median = 1.19. 
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The bar graph below, Figure 3.12, depicts the correlation of the mean CIMT of 
the control group (0 vessel involvement) and that of the groups with one- two- 
and three coronary vessel involvement in the study group. 
 FIGURE 3.12  MEANS AND STANDARD DEVIATIONS OF EXTENT 
                                  OF VESSEL INVOLVEMENT 
Group
Means & Std Devs
0 1 2 3
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The Correlation Coefficients for the groups above are as follows: 
• No CAD (controls): 0.43; 
• One-vessel CAD:  0.41; 
• Two-vessel CAD:  0.28; 
• Three-vessel CAD:  0.35; 
GROUP NO 
CAD 
1 VESSEL 2 VESSELS 3 VESSELS 
AVE 
CIMT 1.00 1.08 1.04 1.29 
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Figure 3.12 shows that the average CIMT for the control group (no CAD), is 
much lower than the average CIMT of the study group, as was stated before. 
Of note is that average CIMT increases with the number of vessel 
involvement. 
Thus increased CIMT was found to correlate well with the extent of vessel 
involvement in CAD. 
 
The findings in my study support previous studies where increased CIMT was 
correlated with evidence of angiographically proven CAD36 8. In the study by 
Geroulakos et al, 1994, they showed that there was a significant positive 
linear trend between CIMT and the number of involved vessels (p<0.0001, 
r=0.44) They demonstrated a high positive predictive value and specificity for 
the presence of CAD if a corrected-for-age CIMT >0.85 mm is used as a cut-
off point for the prediction of severe CAD. They suggested that CIMT could be 
useful as a screening tool in a population with a low prevalence of CAD.  
In the study by Kablak-Ziembicka et al, they also showed that increased CIMT 
was positively and linearly related to CIMT – subjects with a greater number 
of vessel involvement showed greater increases in CIMT. In addition they 
showed that a CIMT over 1.15mm was predictive of a 94% likelihood of 
having CAD. Four independent predictors of CAD were identified: age, 
hyperlipidaemia, smoking and increased CIMT. Hypertension does not seem 
to be as dominant as in my study.  
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 59 
3.10  CONCLUSION 
 
The paucity of research regarding CAD in the Black population of South Africa 
needs serious redress. Two important publications reviewed the situation in 
sub-Saharan Africa. 
• The focus of Opie and Seedat7 was on hypertension and its possible 
causes; 
• Steyn et al6 focused on MI and the risk factors contributing to MI.  
These studies bear testimony to the following quote by Bradlow BA, Zion MM 
and Fleishman SL42: 
 “Africa provides a vast natural laboratory for the study of the aetiology 
and epidemiology of heart disease”. 
 
From these publications, it is clear that hypertension occurs predominantly in 
Blacks. Together with diabetes, they constitute the major risk factors for MI in 
Blacks in Sub-Saharan Africa6. This is similar to the findings in the United 
States, where the prevalence of hypertension in Black Americans (32% ) 
compared to Whites (23%) was demonstrated in the National Health and 
Nutritional Survey (NHANES)43.  
Although exact data concerning the incidence of hypertension in Black South 
Africans is not known, what has been reported, is that the prevalence of 
hypertension as well as MI is increasing and that “hypertension behaves in an 
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explosive manner with deaths often occurring as a result of cerebral 
haemorrhage, uraemia or congestive heart failure”1. 
The INTERHEART Africa study found that hypertension as a risk factor for MI 
was most relevant in Black Africans, with the other known risk factors being 
generally consistent for the three ethnic groups of the study. The most likely 
reason for the increasing incidence of hypertension amongst Black Africans, 
has been attributed to the mass migration from rural to peri-urban and urban 
areas. The consequent acquisition of unhealthy lifestyles, including high-fat, 
low fibre diets and lack of physical exercise resulting in obesity, together with 
smoking, has parallels with the progressively developing situation seen over 
decades in the United States, where with extended exposure to the above risk 
factors, the CAD rates for African Americans has overtaken that for Whites43. 
Opie and Seedat suggest that obesity is a major factor contributing to 
hypertension in South African Blacks, as was found for both West African and 
American blacks7.   
 
Ward Riley, a leader in the field of CIMT in atherosclerosis, makes two 
important points in his editorial comment35. The value of CIMT as a risk factor 
for CAD is succinctly captured in the following statement: “ Large population 
based studies in several countries have now convincingly demonstrated that 
carotid intima-media thickness is a strong predictor of future cardiovascular 
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events in adult men and women… and is nearly as predictive as all of the 
known risk factors combined.”  
My research shows support for CIMT as an independent predictor for CAD. 
Furthermore I have shown that increased CIMT correlates well with the known 
risk factors, including those constituting the Metabolic Syndrome. Using 
multiple regression analysis, the effects of the studied risk factors on the 
CIMT shows that the most significant factors affecting CIMT in my Study 
group were hypertension, high fasting glucose, age and smoking.  
 
Limitations of my research in terms of generalising the findings to the larger 
population need to be stated. The limitations are inherent in the study design, 
which recruited subjects undergoing coronary angiography for a suspected 
clinical diagnosis of CAD. The study population, a total of 53 subjects, was 
thus highly selected, without the possibility of case-matching, particularly for 
the dominant risk factor, hypertension, which was present in every study 
subject but one.  Future researchers will be faced with the challenge of 
recruiting a larger group of participants to allow for a controlled study within 
this population with a rising prevalence of CAD.  Better definition of the impact 
of each of the risk factors on CIMT and consequently CAD should be the role 
of future studies. 
 
Despite these impediments, a number of important perspectives have 
emerged from my study, which would be of value in planning future research 
in this important field:  
 62 
1. The aim of my study was to explore whether ultrasound measurement 
of the CIMT could be used as a surrogate marker for coronary artery 
disease. The cardinal finding in this regard is the good correlation of 
the CIMT with the extent of the coronary vessel involvement in CAD 
(average CIMT values ranging from 1.0 for the control group with no 
CAD at angiography, to 1.29 for those with three vessels involved). 
Ultrasound has thus demonstrated its value as a tool to explore the 
pathogenesis of CAD, and to monitor its expected growth in prevalence 
in the South African Black population. CIMT could play a pivotal role in 
providing solutions, to prevent this population with a low prevalence of 
CAD, from gradually succumbing to the hazards of upward social and 
economic mobility, as was found within the Black population of the 
USA. 
2. The principle risk factor, hypertension, has yet again demonstrated its 
physical effect on the intima-media of arteries as has been seen in 
other studies25. The effect of hypertension on CIMT in my study is 
evident from the following observations: 
• Four subjects had hypertension as the only risk factor for CAD, and 
the CIMT values of this group had a median CIMT percentile value 
(1.22) which was much greater than for subjects with multiple risk 
factors;  
• In subjects with normal and high HDL-C levels, the CIMT was 
increased in a higher proportion (81.8%) than for subjects with a 
low level of HDL-C (68.8%). This finding suggests that hypertension 
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overrides the expected protective effect of normal to increased 
HDL-C levels against CAD in Black South Africans, suggested by 
Opie and Seedat7; 
• Bearing in mind that diabetics were excluded from my study at 
recruitment, the effect of high fasting blood glucose levels on the 
CIMT was significant. There was a good correlation of CIMT against 
fasting blood glucose levels of the whole group in simple linear 
regression analysis (Correlation Coefficient, 0.35; P=0.03). In 
addition, 100% of subjects with a high fasting blood glucose had an 
increased CIMT. Tropeano et al41 found the same in their study 
where they looked at blood glucose levels and CIMT in subjects 
who were hypertensive and had hyperglycaemia. They concluded 
that hyperglycaemia was a major independent determinant of CIMT 
in hypertensive, hyperglycaemic subjects “…offsetting the 
mechanical role of hypertension”. 
What is interesting in my study is the observation that the group of 
subjects with dysfunctional glucose metabolism, as indicated by an 
abnormal glucose tolerance test, have similar increases in CIMT 
values to the group with normal glucose metabolism (normal fasting 
glucose levels and normal glucose tolerance tests). An abnormal 
glucose tolerance test is the earliest manifestation of Type II 
diabetes, and my study did not show that this hyperglycaemic 
state offsets the effect of hypertension. This indicates that 
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hypertension remains the principle determinant of an increased 
CIMT in this population.  
The profound effect of hypertension on the CIMT suggested by my findings 
supports the notion that every measurement, on every patient (except the 
single individual who was normotensive), had been markedly affected by 
hypertension. This would have a masking effect on the impact of the risk 
factors on the measurements of the intima-media in this study. Further 
studies are definitely required, which should incorporate large numbers of 
subjects, matched for all the critical risk factors, to verify this phenomenon. 
Further studies are also needed to define the role of hypertension and a 
raised fasting glucose relative to the other risk factors of the Metabolic 
Syndrome. The effect of the Metabolic Syndrome on the CIMT is an important 
finding in my study, since it is similar to the trends in other studies where 
increased CIMT has been demonstrated in the presence of the Metabolic 
Syndrome38 40. My results have shown that a higher percentage of subjects 
with the MS had increased CIMT as compared to the whole study group, 
87.5% vs. 76% respectively.  
The individual risk factors other than the dominant hypertension and fasting 
high blood glucose levels of the Metabolic Syndrome, demonstrate effects 
which require special consideration: 
• Obesity does not appear to have the striking effect on the CIMT as 
found in other populations with an increasing incidence of CAD, 
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particularly in the African-American population of the United States15. 
Furthermore, in the study of Steyn et al6 abdominal obesity was a 
significantly stronger risk factor for acute MI in the African group than 
the overall INTERHEART group (P<0.0001 for tests of heterogeneity 
of effects). In my study, the percentage of subjects with increased 
CIMT was similar for obese and non-obese subjects, 79.17% and 
78.57% respectively. Once again the effect of hypertension on the 
CIMT in the non-obese subjects needs to be taken into account.  
• The findings of the effects of the lipid components of the Metabolic 
Syndrome need careful consideration. Raised triglyceride levels were 
not strongly associated with increased CIMT, those with normal levels 
had similar associations with the CIMT (79% vs. 73.7%). In the case of 
HDL-cholesterol, as mentioned above, normal to raised levels did not 
protect against the development of dangerous degrees of intima-media 
thickness. In fact, the trends of the CIMT values were the reverse of 
the expected, with increasing HDL-C levels being associated with 
increasing rather than decreasing CIMT values in the linear regression 
module of intima-media thickness against HDL-C levels. Whilst once 
again the masking effect of hypertension needs to be considered, it 
begs the question whether the differences point to a unique situation in 
the Black South African population: 
o Are we witnessing a unique physiological response to 
dysfunctional internal lipid environments? 
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o Does this indicate that we are dealing with a genetically unique 
population? 
OR 
o Are we merely witnessing a society in social and economic 
transition as proposed for the Black population in the United 
States, where hypertension is considered to be due to changes 
in diets and lifestyles associated with a population shift from 
rural to urban? 
These issues open up important research questions: 
1. What should be the structure of research projects to establish the 
effects of rapid urbanisation, a growing economy, the drive for 
improved education and a more affluent lifestyle that is considered 
“better” but is clearly having a disastrous effect on the heath of the 
population? 
2. Are there unique therapeutic interventions, individually and in 
combination that needs to be provided for a possibly unique 
population? 
 
Research outcomes will provide the scientific support for Public Health and 
education programmes for the population: 
• The irony of the negative consequences of development and upward 
social mobility, imperative for social transformation, needs to be 
brought to the attention of the society and policy decision-makers. In 
order to promote healthy lifestyles, the dangers of smoking and 
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obesity as a result of improper diet and lack of exercise in particular, 
need to be the focus of Public Health outreach programmes.  
 
These are huge and important issues, which will require innovative 
approaches in order to provide scientifically sound solutions. Ultrasound 
measurement of the CIMT could be pivotal in providing the scientific basis for 
these solutions in that: 
• It provides, with the correct training and quality control 
protocols, a precise, reproducible and direct measurement of 
the damage caused to arteries. This is important for 
scientifically defining the ‘Response to Injury ‘in the Black 
population of South Africa and the role of risk factors, 
independently and in combination, such as those of the 
Metabolic Syndrome. 
 Such data would provide direction for future fundamental molecular biology 
research into the pathogenesis of atherosclerosis in this population. This is of 
importance for the health of the Black population of South Africa in particular: 
• With the rapidly growing pharmaceutical armamentarium 
against atherosclerosis, each potential agent needs careful 
documentation in terms of its efficacy, specifically in this 
population, where the economy may not allow everyone equal 
access to varieties of pharmaceuticals. Strategic combinations 
of agents may need to be explored for maximal additive effects. 
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For all the reasons stated above, CIMT measurement, properly done, is 
crucial: 
• It is non-invasive and thus acceptable to individuals; 
• It is an investigation which can be accurately done in a relatively 
short space of time, which would be appropriate for large 
studies; 
• In view of the above it could be used in studies across all ages, 
including young children. As the vascular consequences of 
atherosclerosis starts in early childhood, the changes need to 
be studied across the age spectrum and repeated over time 
periods in order to adequately explore the possibility of a unique 
response to internal haemodynamic, rheological and 
biochemical assaults in this population. Accurate ultrasound 
measurements of the CIMT would be absolutely essential for 
such studies; 
• It is very cost-effective relative to the scientific information it 
provides. In this regard, funds spent on procuring reliable and 
accurate equipment would be well spent; 
• In a similar way, making available resources for the provision of 
high quality training of sonographers in the techniques and full 
certification of competence would be a sound investment. This 
will increase the accuracy of the CIMT measurements; 
• Due to the importance of reproducibility in the technique, 
participation in efficient and continuous quality control systems 
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is essential. The value provided will again be well worth the 
cost. 
Ward Riley’s second point in the editorial mentioned above35 is tinged with 
caution. He refers to authors who found that measurement of the CIMT of the 
common carotid artery only is as predictive as all nine other risk factors.  To 
quote del Sol et al34, to whom he refers, “…a single carotid IMT measurement 
is of the same importance as commonly used risk factors in the prediction of 
coronary heart disease and cerebrovascular disease” 
Clearly, the use of CIMT as the sole modality to identify people at risk for 
coronary and cerebrovascular events, without knowing their status in terms of 
the other risk factors, is a revolutionary notion, which perhaps is not fully 
appreciated by the medical community. 
However, he makes a firm statement that the use of multiple sites to 
measure IMT, given the variation in the degree of arterial involvement in 
atherosclerosis, would yield more accurate information and should be the 
chosen protocol. 
 
In conclusion, the use of B-mode ultrasound to measure CIMT should be 
strictly limited to trained and certified persons, in order to maintain its scientific 
validity as a surrogate marker for coronary artery disease, as demonstrated in 
this study. 
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ADDENDUM 2  LINEAR REGRESSION: CIMT WITH AGE 
 
Linear           Y = A + B*X 
 
Y =   .4974  +  .0114  * X 
 
Parameter                         Coefficient               Std Error                         t-Value                     Prob 
Constant (A)                      .497375                    .452573                             1.098995                 .2791 
AGE (B)                             .011402                    .008082                             1.41079                   .1669 
 
Unadjusted r^2                 =  .05239                    Regression ANOVA F    =  1.990327 
Adjusted r^2                     =  .026068                  2-Tailed Prob p       =  .1669 
Correlation Coef               =  .228889                  Degrees of Freedom    =  1 and 36 
 
Std Err of Estimate           =  .399485                  Durbin-Watson Stat    =  .145421 
Variance of Estimate        =  .159588                  Dependent Var. Mean   =  1.129281 
Mean Absolute Error        =  .309714                 Coeff. of Variation   =  .353751 
 
with  X = AGE          and         Y = CIMT 
 
ADDENDUM 3  LINEAR REGRESSION ANALYSIS: CIMT WITH FASTING BLOOD 
                          GLUCOSE LEVELS 
 
Linear           Y = A + B*X 
Y =   .2556  +  .1667  * X 
Parameter                         Coefficient              Std Error                              t-Value                   Prob 
Constant (A)                      .255572                   .39464                                   .647608                  .5213  
GLUCOSE (B)                   .166655                   .07433                                    2.242104               .0312  
 
Unadjusted r^2              =  .12253                      Regression ANOVA F    =  5.027033  
Adjusted r^2                  =  .098156                    2-Tailed Prob p       =  .0312  
Correlation Coef            =  .350043                    Degrees of Freedom    =  1 and 36  
 
Std Err of Estimate        =  .384416                    Durbin-Watson Stat    =  .227331  
Variance of Estimate     =  .147776                    Dependent Var. Mean   =  1.129281  
Mean Absolute Error     =  .292544                    Coeff. of Variation   =  .340408  
                        with  X = GLUCOSE      and      Y = CIMT 
